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Dendritic Cells―Importance in
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Setsuya Aiba1
ABSTRACT
In this review we discuss the role of dendritic cells (DC) in the pathogenesis of allergic contact hypersensitivity
(ACH) and atopic disorders, such as asthma and atopic eczema. In ACH patients, DC recognize the invasion of
simple chemicals such as haptens, and trigger antigen-specific T cell responses leading to the characteristic
histological and clinical changes such as spongiosis and papulovesicular eruptions. During atopic disorders, it
is well known that the Th2-deviated immune response plays a crucial role in their pathogenesis. DC provide T
cells with antigen and costimulatory signals (signals 1 and 2, respectively), as well as with a polarizing signal
(signal 3). When studying ACH, it is important to understand how simple chemicals induce the activation of DC
and their migration to the draining lymph nodes where they supply signals 1 and 2 to naïve T cells. The mecha-
nisms by which DC induce the Th2-deviated immune response, namely via the Th2-deviated signal 3, are cen-
tral topics in the pathogenesis of atopic disorders.
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INTRODUCTION
CURRENT VIEWS ON ALLERGIC CONTACT HY-
PERSENSITIVITY, ASTHMA AND ATOPIC DER-
MATITIS
During allergic contact hypersensitivity (ACH),
chemicals penetrate into the viable layers of the epi-
dermis and into the various cells therein. At these
sites, the chemical must react with a carrier protein
or peptide to form a T cell epitope, and must also acti-
vate epidermal or dermal dendritic cells (DC). The
reaction of haptens with proteins is either covalent or
non-covalent, such as by forming a coordination com-
plex. In addition, haptens activate DC, although the
mechanism by which this occurs is still controversial.
Activation of DC induces the augmented expression
of various co-stimulatory molecules and increased
production of proinflammatory cytokines. Activated
DC start to migrate via the afferent lymphatics to the
draining lymph nodes where they present haptens to
naïve T cells. In the draining lymph nodes, DC
stimulate naïve T cells, helper T cells and cytotoxic T
cells, in an antigen-dependent manner. Moreover,
they may affect the Th1Th2 deviation of the subse-
quent T cell response.
On the other hand, the pathogenesis of both
asthma and atopic dermatitis (AD) is still not fully un-
derstood; however, a central role has been proposed
for allergen-specific T cells that produce Th2 cytoki-
nes such as IL-4 and IL-5. In addition, mast cells and
eosinophils have been shown to exert important ef-
fector functions in these diseases. In both diseases,
IL-4 and IL-13 induce the expression of cell adhesion
molecules in inflamed endothelium and also induce
the production of chemokines in the epithelium, thus
leading to the recruitment of inflammatory cells and
the production of IgE by B cells. IL-5 is important for
the growth, differentiation and activation of tissue
eosinophils, whereas IL-9 is important for mast cell
growth and activation. GM-CSF stimulates the
growth of eosinophils and the activation of antigen-
presenting cells (APC). Moreover, in asthma, cytoki-
nes produced by Th2 cells and inflammatory cells can
affect the airway epithelium, subepithelial (myo-) fi-
broblasts and smooth muscle cells in the lungs, thus
leading to structural abnormalities.
ALLERGIC CONTACT DERMATITIS (Fig. 1)
DENDRITIC CELL MATURATION
DC are the most potent antigen presenting cells for
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Fig. 1 Dendritic cels in alergic contact hypersensitiveity
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helper T cells and cytotoxic T cells.1 They reside in
non-lymphoid organs and show extremely active en-
docytosis and antigen-processing, but weak antigen
presenting functions.2 In response to various stimuli,
immature DC mature, and hence become so called
mature DC. During maturation, the expression of en-
docytic receptors decreases, endocytosis is reduced,3
and the expression of class II-peptide complexes is
stabilized.4,5 In addition, DC undergo significant
changes in the expression of many molecules used to
interact with T cells, such as several B7-family mem-
bers (CD80, CD86, PD-L2B7-DC, ICOS-L), TNF
family members (CD1374-1BBL, CD134OX40L,
CD70), and chemokine receptors (CCR5, CCR7) (re-
viewed by Steinman).6
MATURATION SIGNALS (Fig. 2)
There are many stimuli that induce DC maturation.
These stimuli can be classified into danger signals, in-
nate immunity maturation signals, and adaptive im-
munity maturation signals. Danger signals were first
postulated in 1994 as part of a model of immunity that
suggests that the immune system responds to sub-
stances that cause damage, rather than to those that
are simply foreign.7 They consist of molecules or mo-
lecular structures that are released or produced by
cells undergoing stress or abnormal cell death. Sig-
nals such as TNF-α, IL-1β, type I interferon, intracel-
lular nucleotides such as ATP and UTP, and heat-
shock proteins induce activation in resting DC, and
thus initiate immune responses.8 Indeed, certain
types of necrotic cells can induce maturation in vitro.9
Many microbial ligands and synthetic compounds
can act as innate immunity maturation signals. These
signals act on distinct Toll-like receptors (TLR) to
control DC maturation, e.g., viral RNA and poly IC on
TLR3, mycobacterial extracts on TLR2 and TLR4, imi-
dazoquinolines on TLR7 and bacterial DNA and CpG
deoxyoligonucleotides on TLR 9 (reviewed by Kawai
and Akira).10 In addition, innate cell types such as NK
cells,11,12 γδT cells13 and NKT cells14 can induce the
maturation of DC.
Adaptive immunity maturation signals are com-
posed of CD40-CD40 ligand interactions, antigen-
antibody complexes and Fc receptors. The natural
ligand for CD40 is CD154CD40L, a trimeric TNF-
like molecule that is expressed mainly on activated
Th cells.15 Ligation of CD40 on DC induces matura-
tion that is reflected by the production of high levels
of IL-12, enhanced T cell stimulatory capacity and im-
proved DC survival.16-18 The triggering of CD40 on
DC empowers these cells to activate naïve CD8+
CTL.19 It has been shown that CD40L has a number
of effects on the different blood DC subsets. For ex-
ample, plasmacytoid DC activated by CD40L induce
Th2 differentiation, whereas myeloid DC activated by
CD40L induce Th1 differentiation.20 CD40 ligation by-
passes the need for CD4+ T cell help,21 although
CD40 ligation cannot replace CD4+ T cell help for
CD8+ CTL responses under certain conditions.22 Ag-
Ab immune complexes are able to induce DC matura-
tion in vitro.23-25 This enables DC to prime peptide-
specific CD8+ CTL in vivo, independently of CD4+ Th
cells.25
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Fig. 2 Dendritic cel maturation signals
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HAPTENS AS A MATURATION SIGNAL
We have previously reported that murine LC up-
regulate their expression of class II MHC antigen and
antigen presenting function after hapten painting to
the skin.26 Indeed, chemicals that simply irritate the
skin rather than sensitize animals cannot induce this
phenomenon.26 In addition, we have demonstrated
that the application of haptens to murine skin is ac-
companied by the up-regulation of several co-
stimulatory molecules on LC, including CD40, CD54,
CD80, and CD86.27 In a different study, Enk et al.
demonstrated a crucial role for IL-1β secreted by the
LC themselves, after exposure to hapten applica-
tion.28
In addition to these in vivo studies, we have dem-
onstrated in vitro that purified human monocyte-
derived DC (MoDC) respond to haptens such as
NiCl2 and dinitrochlorobenzen (DNCB), but not to ir-
ritants such as benzalkonium chloride (BC) or so-
dium lauryl sulfate (SLS).29 The mechanism by which
this occurs involves the increased expression of
CD54, CD86, and HLA-DR, and an increased produc-
tion of proinflammatory cytokines. Furthermore, us-
ing Langerhans cell-like DC induced from peripheral
blood monocytes in the presence of transforming
growth factor β1 (TGF-β1), GM-CSF, and IL-4
(MoLC),30 we have shown that in vitro treatment with
haptens can induce the same phenotypic and func-
tional changes in MoLC that are seen in epidermal
LC during the initiation phase of contact hypersensi-
tivity reaction in vivo,31 e.g., the down-regulation of E-
cadherin32 and CLA,33 the induction of MMP-9 ex-
pression,34 and the augmentation of some of β1-
integrins,35,36 CD44 and some of its variants,37 as well
as the expression of CCR7 mRNA that enable LC to
respond to MIP-3β.38-40
HOW DO HAPTENS INDUCE THE MATURATION
OF DC?
A number of studies have addressed the question of
how different haptens stimulate MoDC to acquire a
mature phenotype. Kuhn et al.41 demonstrated that
strong sensitizers could induce the formation of phos-
photyrosine in MoDC in vitro, suggesting that tyro-
sine phosphorylation plays an important role in the
activation of MoDC by haptens. In addition, Arrighi et
al. have recently reported that 2,4-dinitrofluoroben-
zene (DNFB) and NiSO4 induce p38 MAPK phospho-
rylation, and that the augmentation of CD80 and
CD83 induced by NiSO4 is partially suppressed by a p
38 MAPK inhibitor.42
We have also examined the role of MAPKs and NF-
κB in DC stimulated with two representative haptens,
NiCl2 and DNCB.43 Human MoDC stimulated with
DNCB induced the phosphorylation of p38 and
SAPKJNK, while NiCl2 induced that of p4442
ERKs, p38, and SAPKJNK. In addition, NiCl2 phos-
phorylated IκB and activated NF-κB. In contrast, pri-
mary irritants such as benzalkonium chloride (BC)
and sodium lauryl sulfate (SLS), did not activate
these signal transduction pathways. These data indi-
cate that NiCl2 and DNCB stimulate different signal
transduction pathways in MoDC, and subsequently
induce different phenotypic and functional changes.
P38 MITOGEN-ACTIVATED PROTEIN KINASE IS
ACTIVATED BY THE REDOX IMBALANCE IN-
DUCED BY HAPTENS
We examined the mechanism by which p38 MAPK is
activated by sensitizers. Changes in the intracellular
reducedoxidized glutathione ratio (GSHGSSG) are
crucial reduction-oxidation (redox) events, which
transduce oxidative stress into the modulation of
MAPKs and various transcription factors related to
growth, differentiation, and death.44,45 Indeed, p38
has been shown to be phosphorylated by oxidizing
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conditions via ASK1 modulation.46 We therefore
measured the ratio of the oxidized (GSSG) vs. re-
duced (GSH) form (GSHGSSG) of cellular glu-
tathione in MoDC stimulated with various concentra-
tions of haptens, NiCl2, MnCl2, DNCB, thimerosal,
and formaldehyde (HCHO), and non-haptens such as
ZnCl2, SLS, and BC. The results clearly demon-
strated that all the haptens, but none of the non-
haptens, reduced the GSHGSSG ratio in MoDC, ac-
companied by phosphorylation of p38. In addition,
treatment with the antioxidant, N-Acetyl-L-cysteine
(NAC), which suppressed the reduction of the GSH
GSSG ratio in MoDC, abrogated both the phospho-
rylation of p38 and the augmentation of CD86 expres-
sion by MoDC. These data suggest that the GSH
GSSG imbalance plays a crucial role in triggering DC
maturation by sensitizers.
THE ROLE OF ATP RELEASED BY HAPTEN-
TREATED KERATINOCYTES IN THE ACTIVA-
TION OF DC
The release of nucleotides such as ATP or ADP can
be triggered by various environmental stimuli includ-
ing mechanical shear forces, stretch, changes in os-
molarity, oxidative stress, and microbial products.47-53
Indeed, Mizumoto et al. have recently reported that
various irritant chemicals induce ATP release from
keratinocytes.54 Extracellular nucleotides, in turn,
bind to the purinergic type 2 receptors and regulate
cell death, growth, differentiation, migration, and cy-
tokine production.55-58 DC also express a variety of
purinergic receptors and respond to ATP by increas-
ing the membrane expression of CD54, CD80, CD86,
and CD83. This slightly reduces the endocytic activ-
ity of DC, and augments their capacity to promote the
proliferation of allogeneic naïve T lymphocytes.
Moreover, ATP enhances LPS- and soluble CD40
ligand-induced CD54, CD86, and CD83 expression59
Conversely, ATP markedly and dose-dependently in-
hibits LPS- and soluble CD40 ligand-dependent pro-
duction of IL-1α, IL-1β, TNF-α, IL-6, and IL-12,
whereas IL-1 receptor antagonist and IL-10 produc-
tion is not affected. As a result, T cell lines generated
from allogeneic naive CD45RA (+) T cells primed
with DC matured in the presence of ATP, produced
lower amounts of IFN-γ and higher levels of IL-4, IL-5,
and IL-10 compared with T cell lines obtained with
LPS-stimulated DC.59,60 Grabbe et al. have previously
demonstrated that skin irritation is required for reac-
tive haptens to produce allergic contact hypersensitiv-
ity responses.61 Indeed, Mizumoto et al. have demon-
strated that dinitrofuorobenzene,a representative hap-
ten, induces ATP release from keratinocytes.54 Thus,
ATP released by keratinocytes treated with haptens
may contribute to the activation of LC in the initiation
phase of the allergic contact hypersensitivity reaction.
THE MIGRATION OF DC TO THE REGIONAL
LYMPH NODES
Activated DC exhibiting augmented expression of
various co-stimulatory molecules and increased pro-
duction of proinflammatory cytokines start to migrate
via the afferent lymphatics to the draining lymph
nodes where they present haptens to naïve T cells
(below). In order to migrate to the lymph nodes, DC
down-regulate E-cadherin which functions in anchor-
ing epidermal DC or Langerhans cell (LC),32,62 pro-
duce MMP-9 that is required for passing through the
basement membrane,34,63 and increase their expres-
sion of chemokine receptor CCR7 that induces the
migration toward CCL-19 (MIP-3β) and CCL-21
(SLC)39,64 and the consequent lymph node migration
of DC is controlled by signals that are usually found
at sites of inflammation; these include lipid mediators
such as cysteinyl leukotrienes65 and prostaglandins
E2,66-68 and the ADP-ribosyl cyclase CD38.69 It has
been recently reported that the CCR8 receptor for the
chemokine CCL-1 (also known as I-309 in human sub-
jects and TCA-3 in mice) acts in concert with CCR7
during emigration of DCs from the skin and lung.70
INDUCTION OF EFFECTOR T CELLS AND
REGULATORY T CELLS IN THE DRAINING
LYMPH NODES
DC do not only stimulate naïve T cells, but also influ-
ence the differentiation of T cells into Th1, Th2, Th3
or T regulatory cells. The signal to skew emerging T
cell responses is transmitted as signal 3, and is com-
posed of cytokines and other molecules. Cytokine
production by DC is subject to a tight regulation,
which is particularly relevant in the case of IL-12, the
prototypic Th1-polarizing cytokine. IL-12 production
is elicited by most pathogens and is potently boosted
by activated Th cells through CD40L;71 however, it is
not induced by some maturation stimuli, such as
TNF-α, IL-1β, cholera toxin or FasL. IL-12 production
can be modulated by cytokines and mediators pre-
sent during the induction of maturation.72 Thus, IFN-
γ and even IL-4 enhance IL-12 production induced by
the appropriate stimuli, while PGE2 and IL-10 exert
an inhibitory effect. Moreover, IL-12 production by
DC is restricted to a narrow temporal window after
the induction of maturation.73 The capacity to induce
Th2 responses is a property of DC that does not pro-
duce Th1-polarizing cytokines. A substantial portion
of the CD4+ lymphocytes that are recruited in allergic
contact dermatitis (ACD) skin release IFN-γ and be-
long to the Th1 subset. Hapten-specific Th0 as well as
Th2 cells are also represented, and they may effec-
tively cooperate in the amplification of the inflamma-
tory response.74-76
DC are also able to stimulate CD8+ T cells. CD8+ T
lymphocytes are likely to be the major effector popu-
lation in response to chemicals during ACD. CD8+ T
cells (both type 1 and type 2) can exert direct cytotox-
Dendritic Cells in Allergy
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Fig. 3 Dendritic cels in atopic dermatitis
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icity against resting resident cell populations, in par-
ticular keratinocytes, and release cytokines upon anti-
gen encounter.77 In contrast, killing by CD4+ Th1
cells requires the prior treatment of keratinocytes
with IFN-γ to stimulate the expression of MHC class
II molecules and ICAM-1. Moreover, IFN-γ up-
regulates Fas expression and renders keratinocytes
susceptible to FasL-mediated cytotoxicity, which pre-
dominates in Th1 cells.77,78
ATOPIC DERMATITIS AND ASTHMA (Fig. 3)
THE ROLE OF DC IN TH1TH2 DEVIATION
After the activation of T cells, a crucial step in the ad-
ditional tailoring of adaptive immunity is their differ-
entiation into either Th1 or Th2 cells. DC influence
Th1Th2 deviation depending on not only their line-
age, but also the microenvironment of cytokines and
or inflammatory mediators and maturation status.
The most important signal responsible for Th differ-
entiation is the cytokine profile present at the time of
T-cell stimulation. For example, a Th1-inducing pro-
file is represented by IL-12 family members and IFN-
a, whereas a Th2-inducing profile is represented by
IL-4 and IL-10.
In humans, myeloid DC and plasmacytoid DC sub-
sets were initially called DC1 and DC2 respectively,
referring to their capacity to preferentially induce the
differentiation of naïve T cells into Th1 and Th2 ef-
fector cells.20 After CD40 triggering, the subpopula-
tion of DC derived from monocytes in humans and
referred to as DC1, would provoke a type 1 response
by producing high amounts of IL-12. The other sub-
population, derived from plasmacytoid DC in humans
and defined as DC2, produces little IL-12 and could
induce a type 2 response.68 However, plasmacytoid
DC can prime both type 1 and type 2 responses de-
pending on the activation signal they received,79 dem-
onstrating that the phenotype of a given DC subset
cannot be considered as a marker of functionality for
the activation of Th1 vs. Th2 cells.
THE TH2 RESPONSE INDUCED BY DC IN
ATOPIC DISORDERS
Two new mediators have recently been identified that
may act on DCs during allergy to induce Th2 re-
sponses. The first is histamine, which, when added to
monocyte-derived DCs in the presence of lipopolysac-
charide, reduces IL-12 production and the induction
of Th1 responses while enhancing IL-10 production
and Th2 development.80-82
A second mediator is human thymic stromal lym-
phopoietin (TSLP), which is of epithelial origin and is
a DC-based inducer of “inflammatory” Th2 re-
sponses. TSLP is a novel IL-7-like cytokine,83 while
the TSLP receptor (TSLPR) is heterodimeric, consist-
ing of the IL-7R- chain and a common γ receptor-like
chain (TSLPR-γ).84-86 Surprisingly, TSLP was shown
to be highly expressed by keratinocytes in atopic der-
matitis lesions and its expression was associated with
the migration and activation of Langerhans cells. This
suggests for the first time that TSLP might be an
early trigger for DC-mediated allergic inflammation.87
Moreover, TSLP-activated DC induced robust prolif-
eration of naive allogeneic CD4+ T cells, which subse-
quently differentiated into Th2 cells. These Th2 cells
produced the allergy-promoting cytokines IL-4, IL-5,
IL-13, and TNF-α, but did not produce IL-10 or
interferon-γ.87 Recently, it has been demonstrated
that TSLP induces human myeloid DC to express the
TNF superfamily protein OX40L at both the mRNA
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and protein level.88 The expression of OX40L by
TSLP-DC was shown to be important for the induc-
tion of inflammatory Th2 cells, as blocking OX40L
with a neutralizing antibody inhibited the production
of Th2 cytokines and TNF-α, and enhanced the pro-
duction of IL-10, by the CD4+ T cells.88 In addition to
atopic dermatitis, a more recent study showed by in
situ hybridization that TSLP expression was in-
creased in asthmatic airways and correlated with
both the expression of Th2-attracting chemokines
and with disease severity,89 thus providing the first
link between TSLP and human asthma.
Finally, Yoo et al. demonstrated that mice engi-
neered to overexpress TSLP in their skin developed
atopic dermatitis characterized by eczematous skin
lesions containing inflammatory cell infiltrates, a dra-
matic increase in circulating Th2 cells and elevated
serum IgE.90 In addition, Zhou et al. showed that
lung-specific expression of a TSLP transgene induced
allergic airway inflammation (asthma) characterized
by a massive infiltration of leukocytes (including Th2
cells), goblet cell hyperplasia, and subepithelial fibro-
sis, as well as increased serum IgE levels.91
CONCLUSION
DC play a key role in the initiation of the immune re-
sponse. Derived from bone marrow precursors, DC
colonize the skin and bronchial mucosa where they
form a tight surveillance network for the immune sys-
tem. Once haptens or allergens enter the epithelia,
DC react with these antigens and stimulate the ac-
quired immune response. The magnitude and charac-
teristics of the response is determined during this
process. DC therefore play a crucial role in the patho-
genesis of allergic diseases.
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